Serica Technologies is a growth-stage medical device company founded in 1998, specializing in silk-based biomaterial platforms for tissue repair. The company's innovative approach combines the purity, strength, and elegance of natural silk with advancements in biomedical engineering to address significant unmet clinical needs in the repair of damaged connective tissue resulting from disease, trauma, or aging. In February 2007, Serica Technologies secured a significant $12.00M Series C investment from Morningside Ventures and Prism Venture Management. The company operates within the Biotechnology and Health Care industries and continues to demonstrate strong potential for growth and influence in the medical device sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | $12.00M | 2 |
|
28 Feb 2007 |
| Series B | $5.02M | - | 22 Jul 2004 |
No recent news or press coverage available for Serica.
We care about your data, and we'd love to use cookies make your experience better.
